Muhammed Mustafa Atci

Spesialisasi: Clinical oncologist
15 tahun pengalaman
Berbahasa:
English, Turkish
Konsultasi online: tersedia
Tempat kerja: Turquia, Istambul, İstinye University Liv Hospital Topkapı
Member of the American Society of Clinical Oncology (ASCO) since 2018.
Dr. Muhammed Mustafa Atci is an Associate Professor of Medical Oncology at İstinye University, Liv Hospital Topkapı (2025–present). He previously served as Associate Professor and Education Coordinator at Prof. Dr. Cemil Taşcıoğlu City Hospital (2023–2025). He was also a Medical Oncologist there (2018–2021).

He has been a member of ASCO and the Turkish Society of Medical Oncology since 2018. He is the author or co-author of 19 peer-reviewed international papers on colon, breast, gastric, pancreatic, lung, thyroid, sarcoma, and colorectal cancers.

Notable works include a multicentre study on stage IIB colon cancer survival (Journal of Chemotherapy). He also studied the De Ritis ratio for lung metastasis in testicular cancer (Current Urology). His prognostic studies used PET/CT, MSI, lymph node ratio, and metabolic tumor volume.

Konsultasi online dengan Muhammed Mustafa Atci

Mudah dan praktis

100% aman dan rahasia

Harga berdasarkan permintaan

Layanan dokter

Lihat lagi

Bagaimana pelayanan kami?

1 dari 3

Informasi tentang dokter ini lengkap dan jelas.

Sangat tidak setuju

Sangat setuju

Kualifikasi

Education

Doctor of Medicine (M.D.)
2003 – 2009
Istanbul University – Cerrahpaşa Faculty of Medicine, Turkey

Residency in Internal Medicine
2011 – 2015
University of Health Sciences – Istanbul Şişli Hamidiye Etfal Health Application and Research Center, Department of Internal Medicine, Turkey

Professional Experience

Internal Medicine Specialist
2015 – 2017
Tokat State Hospital, Turkey

Internal Medicine Specialist
2017 – 2018
Istanbul Haseki Training and Research Hospital, Turkey

Medical Oncologist
2018 – 2021
University of Health Sciences – Istanbul Prof. Dr. Cemil Taşcıoğlu City Health Application and Research Center, Department of Internal Medicine / Oncology Department, Turkey

Associate Professor of Medical Oncology & Education Coordinator
2023 – 2025
Ministry of Health – Prof. Dr. Cemil Taşcıoğlu City Hospital, Turkey

Education Coordinator for the Medical Oncology Sub-Branch

Associate Professor of Medical Oncology
2025 – Present
İstinye University, Liv Hospital Topkapı, Turkey

Memberships to Scientific Organizations

American Society of Clinical Oncology (ASCO) – Member since 2018

Turkish Society of Medical Oncology – Member since 2018

Articles Published in Peer-Reviewed International Journals

1. Atcı, M. M., Akagündüz, B., Demir, M., Arıkan, R., Ay Ersoy, S., Özer, M., Ayhan, M., Çil, İ., Demir, N., Özyurt, N., Karakaya, G., Çevik, G. T., Önder, A. H., Selvi, O., Sakin, A. (2023). The impact of adjuvant oxaliplatin and tumor sidedness on the overall survival of stage IIB colon cancer patients: a multicentre study. Journal of Chemotherapy.

2. Bozkurt, M., Aghalarov, S., Atcı, M. M., Selvi, O., Canat, H. L. (2022). A new biomarker for lung metastasis in non-seminomatous testicular cancer: De Ritis Ratio. Current Urology.

3. Dülgar, Ö., Öven, B. B., Atcı, M. M., Arıkan, R., Ay Ersoy, S., Ayhan, M., Selvi, O., Tataroğlu Özyükşeler, D., Bayram, E., Özcan, E., Yasin, A. İ., Gümüş, M. (2022). Is the benefit of using adjuvant capecitabine in patients with residual triple-negative breast cancer related to pathological response to neoadjuvant chemotherapy? Expert Review of Anticancer Therapy.

4. Akagündüz, B., Altın, Z., Atcı, M. M., Özer, M., Güven, D. C., Çil, İ., Özçiçek, F., Demirtaş, L., Düzgün, E., Gunderci, A., Arslan, Y. (2021). Assessment of abuse and related factors in older patients with cancer. Supportive Care in Cancer.

5. Akagündüz, B., Özer, M., Karaçin, C., Atcı, M. M., Yıldırım, H. Ç., Ünver, E. (2021). Impact of coronaphobia on treatment and follow-up compliance of cancer patients. Future Oncology.

6. Arıcı, S., Sağlampınar Karyağar, S., Uslu Erdemir, R., Çekin, R., Atcı, M. M., Güven, O., Karyağar, S., Cihan, Ş. (2021). The correlation between tumor markers and Ga-68 DOTA-TATE PET/CT findings in patients with advanced medullary thyroid cancer. Revista Española de Medicina Nuclear e Imagen Molecular.

7. Atcı, M. M., Gerede, Ç., Ay Ersoy, S., Ertürk, B., Seçmeler, Ş., Arıcı, S., Çekin, R., Yaşar, N., Can, O., Cihan, Ş., Gümüş, M. (2021). Clinical and pathological characteristics of patients with high-risk breast cancer based on BRCA mutation profiles: A retrospective study. European Journal of Breast Health.

8. Calm, A., Atcı, M. M., Aldemir, M. N., Akagündüz, B., Şahin, S., Arıcı, S., Seçmeler, Ş., Cihan, Ş. (2021). The prognostic value of postoperative lymph node ratio in neoadjuvant-treated gastric adenocarcinoma patients. Cureus.

9. Calm, A., Şahin, S., Sağlampınar Karyağar, S., Karyağar, S., Atcı, M. M., Akbörü, M. H., Cihan, Ş. (2021). The predictive value of baseline volumetric PET/CT parameters on treatment response and prognosis in locally advanced rectal cancer treated with neoadjuvant chemoradiotherapy. Journal of Gastrointestinal Cancer.

10. Arıcı, S., Şengiz Erhan, S., Geredeli, Ç., Atcı, M. M., Seçmeler, Ş., Çekin, R., Sakin, A., Cihan, Ş. (2021). The prognostic importance of microsatellite instability status in Turkish stage II and III gastric cancer patients who received adjuvant chemotherapy. International Journal of Hematology and Oncology.

11. Calm, A., Şahin, S., Atcı, M. M., Ayşegül, P., Yaşar, N., Geredeli, Ç., Aksaray, F., Cihan, Ş. (2021). The effect of different treatment modalities on survival in elderly patients with locally advanced non-small cell lung cancer. Pulmonology.

12. Ayşegül, P., Şahin, S., Abdullah, P., Atcı, M. M., Geredeli, Ç., Cihan, Ş. (2021). Effect of type 2 diabetes mellitus on survival in metastatic pancreatic cancer. Journal of Surgery and Medicine (JOSAM).

13. Akagündüz, B., Akın Telli, T., Yıldırım, H. Ç., Sezgin Göksu, S., Demir, N., Hafızoğlu, E., Özer, M., Çevik, G. T., Sakin, A., Göktaş, A. S., Şengül Samancı, N., Özyurt, N., Atcı, M. M., Ayhan, M., Turan, M., Sarıyar, N., Karaçin, C., Kılıçkap, S., Paydaş, S., Doğan, M. (2021). Factors affecting survival in retroperitoneal sarcomas treated with upfront surgery: A real-world study by Turkish Oncology Group. International Journal of Hematology and Oncology.

14. Calm, A., Şahin, S., Atcı, M. M., Yaşar, N., Demir, C., Geredeli, Ç., Sakin, A., Cihan, Ş. (2020). The effect of body mass index on treatment outcomes in patients with metastatic non-small cell lung cancer treated with platinum-based therapy. Nutrition and Cancer.

15. Ayşegül, P., Şahin, S., Abdullah, P., Atcı, M. M., Yaşar, N., Arıcı, S., Geredeli, Ç., Karataş, F., Cihan, Ş. (2020). Assessment of pre-treatment albumin-bilirubin grade in pancreatic cancer patients with liver metastases. Journal of BUON.

16. Abdullah, P., Süleyman, Ş., Ayşegül, P., Atcı, M. M., Serdar, A., Yaşar, N., Demir, C., Geredeli, Ç., Cihan, Ş. (2020). Factors affecting survival in operated pancreatic cancer; Does tumor localization have a significant effect on treatment outcomes? Northern Clinics of Istanbu.

17. Arıcı, S., Sağlampınar Karyağar, S., Karyağar, S., Geredeli, Ç., Çekin, R., Seçmeler, Ş., Atcı, M. M., Sakin, A., Cihan, Ş. (2020). The predictive role of metabolic tumor volume on non-response to neoadjuvant chemotherapy in patients with breast cancer. Journal of Oncology Pharmacy Practice.

18. Calm, A., Yılmaz, Y., Şahin, S., Atcı, M. M., Arıcı, S., Geredeli, Ç., Yaşar, N., Demir, C., Cihan, Ş. (2020). Factors affecting survival in esophageal squamous cell carcinoma: Single-center experience. Northern Clinics of Istanbul.

19. Calm, A., Şahin, S., Atcı, M. M., Yaşar, N., Geredeli, Ç., Arıbal, S., Alemdar, A., Karataş, F., Cihan, Ş. (2019). Factors affecting survival in patients with isolated liver-metastatic colorectal cancer treated with local ablative or surgical treatments for liver metastasis. Journal of BUON.